top of page
Me Professional AI.png
Angelica Phillips, PhD

Founder, Bellemina Tx Consulting
Bay Area, California, USA
phone: 1-650-727-2082
email: aphillips@belleminatx.com

  • Linkedin

Since July 2020, Bellemina Tx Consulting has partnered with biotech and mid-size pharmaceuticals companies by providing a scalable, on‑demand team model supported by a trusted bench of specialized professionals with over 180 years of combined expertise.

 

Our approach is designed to align with your timeline and budget while delivering and executing on drug product development strategy precisely tailored to your program and organizational needs. 

Services provided range from early R&D development strategy to hands-on execution leading to IND/CTA/IDE submissions and life cycle management with successful outcomes in NDA/BLA approvals.


Founded by an executive with nearly three decades of preclinical drug development technical leadership and a strong record of successful regulatory submissions.

Regulatory

Tailored Strategic Development 
Cross-Functional Integration
Target Product Profile 
First-in-Human Dose
Impurities and Leachable

Write-up of Documents
pre-IND, IND, CTA, NDA
BLA, IDE, IB

Type B Meetings, INTERACT
Orphan Drug Designation
Adults and Pediatrics
Representation to FDA/MHRA
Regulatory Submissions 
GLP and GMP compliance
CBER/CDER/CDRH
ICH/FDA/EMA/IACUC

 

Technical

Manufacturing
Clinical Pharmacology
Quality Assurance
Quality Control
Preclinical
Toxicology
Pharmacology
Pharmacokinetics
Safety Assessment
PK/PD Modeling
Pop PK
ADME/DMPK
Drug-Drug Interaction
QT/QTc studies
CYP inhibition
CYP induction
Metabolites
Assay Validation
Biomarker
Target Engagement
Created IP Positions 
Program Leadership

Operational

POC/Safety Studies Design
Protocol and Report Review
Phase I/II protocols
Data Interpretation
CROs/CDMOs Monitoring
IND-enabling GLP Studies
Team Management
Project Management
Technical/Program Lead
Program Gantt Chart


 

Drug Products
AAV Gene Therapy, Small Molecules, Biologics, Conjugated Drugs, Oligonucleotides

Routes of Administration
IV, Oral, SC, IP, IM, Nasal, Intrapleural, Subretinal, Intravitreal, Intrathecal, ICM

Numerous Indications (see FOUNDER CV and CLIENTS pages)

©2026 Bellemina Therapeutics LLC

bottom of page